Stock listing

A2QQ2E Stock Price, News, Filings & Events — Immunitybio, Inc.

Selected listing: A2QQ2E · LSX · EUR · DE

A2QQ2E:LSX is the listing for Immunitybio, Inc., a biotechnology company dedicated to developing innovative immunotherapy solutions for various diseases. With a market capitalization of around $8.04 billion, Immunitybio is recognized for its commitment to advancing healthcare through cutting-edge research. The company continues to make strides in the biotechnology sector, with ongoing developments and updates that reflect its focus on improving patient outcomes. Recent news and filings highlight its progress and strategic initiatives in the market.

A2QQ2E:LSXEURDEUpdated July 31, 2026
Immunitybio, Inc. logo
Ticker
A2QQ2E:LSX
Asset type
Stock
Market cap
$7.51B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
LSX
Currency
EUR

Immunitybio, Inc. A2QQ2E:LSX stock context

A2QQ2E:LSX is the listing for Immunitybio, Inc., a biotechnology company dedicated to developing innovative immunotherapy solutions for various diseases. With a market capitalization of around $8.04 billion, Immunitybio is recognized for its commitment to advancing healthcare through cutting-edge research. The company continues to make strides in the biotechnology sector, with ongoing developments and updates that reflect its focus on improving patient outcomes. Recent news and filings highlight its progress and strategic initiatives in the market.

Research Immunitybio, Inc.

Alternate listings